12 July
2024
Assura plc
("the
Company")
Notification of transaction
by Persons Discharging Managerial Responsibilities ("PDMRs") and
connected persons
Assura plc ("Assura"), the
specialist healthcare property investor and developer announces
that on 8 July 2024, the following named PDMRs were granted the
following share options over Ordinary Shares of 10 pence each in
the Company under the Company's Performance Share Plan
("PSP").
PDMR
|
Position
|
Number of Share Options Granted
|
Jonathan Murphy
|
CEO
|
1,905,505
|
Jayne Cottam
|
CFO
|
1,269,599
|
These options are subject to three
performance conditions which will be determined after the 2026/27
financial year. 33% of the option shares are subject to a
Total Shareholder Return ("TSR") performance condition, 33% of the
option shares are subject to a Total Accounting Return ("TAR")
performance condition and the remaining 33% are subject to ESG
measures related to portfolio energy reduction targets (energy
usage intensity, "EUI") and net zero carbon developments.
Details of the performance conditions are set out in the Company's
Directors' Remuneration Report for 2023/24.
In addition, the following PDMRs
were granted restricted share options over Ordinary Shares of 10
pence each in the company under the PSP.
PDMR
|
Position
|
Number of Restricted Share Options Granted
|
Orla Ball
|
General Counsel
|
88,474
|
Robert James
|
Group Development
Director
|
88,474
|
Sarah Taylor
|
Chief People Officer
|
88,474
|
The Notification of Dealing Forms
can be found below.
This notification is made in
accordance with the Market Abuse Regulation.
Notification of dealing form
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a)
|
Name
|
Jonathan Murphy
|
2
|
Reason for the notification
|
a)
|
Position/status
|
CEO
|
b)
|
Initial notification/
Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Assura plc
|
b)
|
LEI
|
21380026T19N2Y52XF72
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Share options over ordinary shares
of 10 pence each
GB00BVGBWW93
|
b)
|
Nature of the transaction
|
Grant of options under the
PSP
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£NIL GBP
|
1,905,505
|
|
d)
|
Aggregated information
- Aggregated volume
-
Price
|
Aggregate Price
|
Aggregate Volume
|
Aggregate Total
|
£NIL GBP
|
1,905,505
|
£NIL GBP
|
|
e)
|
Date of the transaction
|
08/07/2024
|
f)
|
Place of the transaction
|
XLON
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a)
|
Name
|
Jayne Cottam
|
2
|
Reason for the notification
|
a)
|
Position/status
|
CFO
|
b)
|
Initial notification/
Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Assura plc
|
b)
|
LEI
|
21380026T19N2Y52XF72
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Share options over ordinary shares
of 10 pence each
GB00BVGBWW93
|
b)
|
Nature of the transaction
|
Grant of options under the
PSP
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£NIL GBP
|
1,269,599
|
|
d)
|
Aggregated information
- Aggregated volume
-
Price
|
Aggregate Price
|
Aggregate Volume
|
Aggregate Total
|
£NIL GBP
|
1,269,599
|
£NIL GBP
|
|
e)
|
Date of the transaction
|
08/07/2024
|
f)
|
Place of the transaction
|
XLON
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a)
|
Name
|
Orla Ball
|
2
|
Reason for the notification
|
a)
|
Position/status
|
General Counsel
|
b)
|
Initial notification/
Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Assura plc
|
b)
|
LEI
|
21380026T19N2Y52XF72
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Share options over ordinary shares
of 10 pence each
GB00BVGBWW93
|
b)
|
Nature of the transaction
|
Grant of restricted share options
under the PSP
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£NIL GBP
|
88,474
|
|
d)
|
Aggregated information
- Aggregated volume
-
Price
|
Aggregate Price
|
Aggregate Volume
|
Aggregate Total
|
£NIL GBP
|
88,474
|
£NIL GBP
|
|
e)
|
Date of the transaction
|
08/07/2024
|
f)
|
Place of the transaction
|
XLON
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a)
|
Name
|
Robert James
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Group Development
Director
|
b)
|
Initial notification/
Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Assura plc
|
b)
|
LEI
|
21380026T19N2Y52XF72
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Share options over ordinary shares
of 10 pence each
GB00BVGBWW93
|
b)
|
Nature of the transaction
|
Grant of restricted share options
under the PSP
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£NIL GBP
|
88,474
|
|
d)
|
Aggregated information
- Aggregated volume
-
Price
|
Aggregate Price
|
Aggregate Volume
|
Aggregate Total
|
£NIL GBP
|
88,474
|
£NIL GBP
|
|
e)
|
Date of the transaction
|
08/07/2024
|
f)
|
Place of the transaction
|
XLON
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
a)
|
Name
|
Sarah Taylor
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Chief People Officer
|
b)
|
Initial notification/
Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Assura plc
|
b)
|
LEI
|
21380026T19N2Y52XF72
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Share options over ordinary shares
of 10 pence each
GB00BVGBWW93
|
b)
|
Nature of the transaction
|
Grant of restricted share options
under the PSP
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£NIL GBP
|
88,474
|
|
d)
|
Aggregated information
- Aggregated volume
-
Price
|
Aggregate Price
|
Aggregate Volume
|
Aggregate Total
|
£NIL GBP
|
88,474
|
£NIL GBP
|
|
e)
|
Date of the transaction
|
08/07/2024
|
f)
|
Place of the transaction
|
XLON
|
- Ends
-
For more information, please
contact:
Assura plc
|
Tel: 0161 515 2043
|
Orla Ball, General Counsel
David Purcell, Investor Relations
Director
|
Email: Investor@assura.co.uk
|
FGS
Global
Gordon Simpson
Grace Whelan
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is the UK's leading
specialist healthcare property investor and developer. Assura
enables better health outcomes through its portfolio of more than
600 healthcare buildings, from which over six million patients are
served.
A UK REIT based in Altrincham,
Assura is a constituent of the FTSE 250 and the EPRA* indices. As
at 31 March 2024, Assura's portfolio was valued at £2.7 billion and
has a strong track record of growing financial returns and
dividends for shareholders.
At Assura, we BUILD for health,
having developed over 100 new healthcare buildings in our history,
and at the heart of our strategy sits The Bigger Picture; Healthy
Environment (E), Healthy Communities (S), Healthy Business
(G).
Further information is available
at www.assuraplc.com
*EPRA is a registered trademark of
the European Public Real Estate Association.